J&J MedTech surgical robotics division developing the OTTAVA robotic surgical system and VELYS orthopedic robot.
Johnson & Johnson MedTech is the medical technology segment of Johnson & Johnson, headquartered in New Brunswick, New Jersey. The division develops surgical robotics platforms including the OTTAVA robotic surgical system for soft-tissue general surgery, the VELYS robotic-assisted solution for orthopedic procedures, and the Monarch endoscopy platform. OTTAVA, submitted to the FDA for De Novo clearance in January 2026, is designed for minimally invasive upper abdominal procedures and completed its first clinical cases in 2025.
J&J MedTech integrates robotics, digital surgery, and advanced energy devices to offer a comprehensive ecosystem across multiple surgical specialties on a global scale.
Primary type & automation activities this supplier delivers:
J&J MedTech soft-tissue robotic surgical platform for general and abdominal surgery.
Contact Johnson & Johnson MedTech
WEBSITE
https://jnj.comPHONE
+1 (732) 524-0400HEADQUARTERS
United States
Company Facts
Founded
1886
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
